ERBB2 and breast cancer: In recent years, several studies have shown the predictive and prognostic value of visually scored TILs in triple-negative BC (TNBC) and human epidermal growth factor receptor 2 (HER2+) BC, making TILs a powerful clinical biomarker [3,4].